Tag: Caladrius Biosciences
December 2, 2019
Top 10 Stem Cell Companies On The NASDAQ
The global stem cell therapy market is expected to grow at a CAGR of 36.52 percent between 2017 and 2021....
September 23, 2018
5 Top Weekly NASDAQ Biotech Stocks: Molecular Templates on Top
Molecular Templates, Galectin Therapeutic, Chiasma, ZioPharm Oncology and Caladrius Biosciences were last week's top gainers on the NASDAQ Biotechnology Index.
September 17, 2018
Investing in Glucose Monitoring Devices
Diabetes is one of the 10 top killers around the world, and as the healthcare industry races to accommodate growing demand...
July 4, 2018
5 Top NASDAQ Pharma Stocks of Q2 2018
About half way through 2018 finishing the second quarter, the INN takes a look at the 5 top pharma stocks... March 23, 2018
Caladrius Biosciences Reports 2017 Fourth Quarter and Year End Financial Results
Caladrius Biosciences (Nasdaq:CLBS) a development-stage biopharmaceutical company with multiple technology platforms targeting autoimmune and select cardiovascular indications, announces financial results... January 18, 2018